Concepedia
Statistics
Publications
20
Citations
3.7K
H-Index
15
Active since
2012
Affiliations
Denali Therapeutics (United States)(Current)
Allergy Associates Research Center
University of British Columbia
University of Rochester
Oklahoma Medical Research Foundation
Romeo Maciuca is an author at Denali Therapeutics (United States) specializing in pharmacology, life sciences, and medicine.
Publications per year
2012–2023
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
Brad H. Rovin, Richard Furie, Kevin Latinis et al. · Arthritis & Rheumatism · 2012 · 1.4K citations
Medicine, Immunology, Pharmacotherapy +16
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
Nicola A. Hanania, Michael Noonan, Jonathan Corren et al. · Thorax · 2015 · 377 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +14
Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double‐Blind, Phase III Study
Eduardo Mysler, Alberto Spindler, Renato Guzmán et al. · Arthritis & Rheumatism · 2013 · 354 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +13
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)
Kenneth Kalunian, Joan T. Merrill, Romeo Maciuca et al. · Annals of the Rheumatic Diseases · 2015 · 339 citations
Pharmacy, Pharmacology, Pharmacotherapy +17
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease
Danna Jennings, Sarah Huntwork‐Rodriguez, Anastasia G. Henry et al. · Science Translational Medicine · 2022 · 252 citations
Life Sciences, Neuroscience, Pharmacology +17
1–5 of 20